Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.

Curtis JR, Mariette X, Gaujoux-Viala C, Blauvelt A, Kvien TK, Sandborn WJ, Winthrop K, de Longueville M, Huybrechts I, Bykerk VP.

RMD Open. 2019 May 31;5(1):e000942. doi: 10.1136/rmdopen-2019-000942. eCollection 2019.

2.

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.

3.

Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.

Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C.

Arthritis Care Res (Hoboken). 2020 Jan;72(1):36-40. doi: 10.1002/acr.23826.

PMID:
30629341
4.

Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.

Beltai A, Barnetche T, Daien C, Lukas C, Gaujoux-Viala C, Combe B, Morel J.

Arthritis Care Res (Hoboken). 2020 Jan;72(1):131-139. doi: 10.1002/acr.23821.

PMID:
30570824
5.

Update of French society for rheumatology recommendations for managing rheumatoid arthritis.

Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M, Fautrel B, Mariette X, Nayral N, Richez C, Saraux A, Thibaud G, Wendling D, Gossec L, Combe B.

Joint Bone Spine. 2019 Mar;86(2):135-150. doi: 10.1016/j.jbspin.2018.10.002. Epub 2018 Oct 10.

PMID:
30315988
6.

Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.

Szafors P, Che H, Barnetche T, Morel J, Gaujoux-Viala C, Combe B, Lukas C.

Osteoporos Int. 2018 Nov;29(11):2389-2397. doi: 10.1007/s00198-018-4586-6. Epub 2018 Jun 16.

PMID:
29909470
7.

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology.

Marteau P, Adamsbaum C, Rossi-Semerano L, De Bandt M, Lemelle I, Deslandre C, Tran TA, Lohse A, Solau-Gervais E, Sordet C, Pillet P, Bader-Meunier B, Wipff J, Gaujoux-Viala C, Breton S, Devauchelle-Pensec V.

Eur Radiol. 2018 Sep;28(9):3963-3976. doi: 10.1007/s00330-018-5304-7. Epub 2018 Mar 26. Review.

8.

Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.

Gossec L, Kirwan JR, de Wit M, Balanescu A, Gaujoux-Viala C, Guillemin F, Rat AC, Saraux A, Fautrel B, Kvien TK, Dougados M; RAID investigators.

Clin Rheumatol. 2018 Jun;37(6):1503-1510. doi: 10.1007/s10067-018-3998-1. Epub 2018 Feb 21.

PMID:
29468340
9.

Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C.

Ann Rheum Dis. 2018 Jan;77(1):98-103. doi: 10.1136/annrheumdis-2017-211836. Epub 2017 Sep 25. Review.

PMID:
28970215
10.

Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.

Gaujoux-Viala C, Rincheval N, Dougados M, Combe B, Fautrel B.

Ann Rheum Dis. 2017 Dec;76(12):2054-2060. doi: 10.1136/annrheumdis-2017-211268. Epub 2017 Sep 2.

PMID:
28866645
11.

Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: Systematic review and meta-analysis.

Letaief H, Lukas C, Barnetche T, Gaujoux-Viala C, Combe B, Morel J.

Joint Bone Spine. 2018 Jan;85(1):15-22. doi: 10.1016/j.jbspin.2017.06.004. Epub 2017 Jun 30.

PMID:
28673789
12.

The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts.

Boeters DM, Gaujoux-Viala C, Constantin A, van der Helm-van Mil AHM.

Semin Arthritis Rheum. 2017 Oct;47(2):170-174. doi: 10.1016/j.semarthrit.2017.04.009. Epub 2017 Apr 29.

PMID:
28601249
13.

The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.

Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT.

Rheumatology (Oxford). 2017 Jul 1;56(7):1244. doi: 10.1093/rheumatology/kew472. No abstract available.

14.

Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross-Sectional Multicenter Study.

Couderc M, Tatar Z, Pereira B, Tiple A, Gilson M, Fautrel B, Pouplin S, Dernis E, Gossec L, Gaujoux-Viala C, Soubrier M, Dougados M.

Arthritis Care Res (Hoboken). 2016 May;68(5):638-44. doi: 10.1002/acr.22713.

15.

The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.

Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT.

Rheumatology (Oxford). 2015 Dec;54(12):2166-70. doi: 10.1093/rheumatology/kev254. Epub 2015 Jul 14. Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1244.

16.

Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.

van Nies JA, Alves C, Radix-Bloemen AL, Gaujoux-Viala C, Huizinga TW, Hazes JM, Brouwer E, Fautrel B, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Apr 23;17:108. doi: 10.1186/s13075-015-0616-3.

17.

Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.

Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, Rader T, Stacey D, Légaré F, Jull J, Petkovic J, Scholte-Voshaar M, Welch V, Lyddiatt A, Hofstetter C, De Wit M, March L, Meade T, Christensen R, Gaujoux-Viala C, Suarez-Almazor ME, Boonen A, Pohl C, Martin R, Tugwell PS.

J Rheumatol. 2015 Dec;42(12):2442-7. doi: 10.3899/jrheum.141205. Epub 2015 Apr 15. Review.

18.

Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.

van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):806-12. doi: 10.1136/annrheumdis-2014-206047. Epub 2015 Jan 5.

PMID:
25561360
19.

Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis.

Gaujoux-Viala C, Gossec L, Cantagrel A, Dougados M, Fautrel B, Mariette X, Nataf H, Saraux A, Trope S, Combe B; French Society for Rheumatology.

Joint Bone Spine. 2014 Jul;81(4):287-97. doi: 10.1016/j.jbspin.2014.05.002. Epub 2014 Jun 27.

20.

When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.

Gaujoux-Viala C, Gossec L.

Ann N Y Acad Sci. 2014 May;1318:32-40. doi: 10.1111/nyas.12452. Epub 2014 May 14. Review.

PMID:
24827544
21.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, van der Heijde D, Winthrop K, Landewé R.

Ann Rheum Dis. 2014 Mar;73(3):529-35. doi: 10.1136/annrheumdis-2013-204575. Epub 2014 Jan 8. Review.

PMID:
24401994
22.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH.

Ann Rheum Dis. 2014 Mar;73(3):516-28. doi: 10.1136/annrheumdis-2013-204577. Epub 2014 Jan 7. Review. Erratum in: Ann Rheum Dis. 2015 Jan;74(1):320.

PMID:
24399231
23.

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L.

Ann Rheum Dis. 2014 Mar;73(3):510-5. doi: 10.1136/annrheumdis-2013-204588. Epub 2014 Jan 6. Review.

24.

C-reactive protein versus erythrocyte sedimentation rate in estimating the 28-joint disease activity score.

Gaujoux-Viala C.

J Rheumatol. 2013 Nov;40(11):1785-7. doi: 10.3899/jrheum.131042. No abstract available.

PMID:
24187153
25.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D.

Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.

26.

[The rheumatoid hand].

Henry J, Roulot E, Gaujoux-Viala C.

Presse Med. 2013 Dec;42(12):1607-15. doi: 10.1016/j.lpm.2012.08.007. Epub 2013 Oct 14. Review. French.

PMID:
24134815
27.

[Medical and economic aspects of rheumatoid arthritis].

Fautrel B, Gaujoux-Viala C.

Bull Acad Natl Med. 2012 Oct;196(7):1295-305; discussion 1305-6. Review. French.

PMID:
23815015
28.

[Microcrystalline arthropathies].

Gaujoux-Viala C.

Rev Prat. 2012 Oct;62(8):1076. French. No abstract available.

PMID:
23227601
29.

[Rheumatoid connective diseases].

Gaujoux-Viala C.

Rev Prat. 2012 Oct;62(8):1074. French. No abstract available.

PMID:
23227600
30.

[Spondyloarthropathies].

Gaujoux-Viala C.

Rev Prat. 2012 Oct;62(8):1072. French. No abstract available.

PMID:
23227599
31.

[The main directions in case of polyarthritis].

Gaujoux-Viala C.

Rev Prat. 2012 Oct;62(8):1069-76. French.

PMID:
23227598
32.

Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis.

Hosseini K, Gaujoux-Viala C, Coste J, Pouchot J, Fautrel B, Rat AC, Guillemin F.

Best Pract Res Clin Rheumatol. 2012 Oct;26(5):627-35. doi: 10.1016/j.berh.2012.08.007. Review.

PMID:
23218427
33.

Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.

Gaujoux-Viala C, Fautrel B.

Pharmacoeconomics. 2012 Dec 1;30(12):1145-56. doi: 10.2165/11596490-000000000-00000. Review.

PMID:
23098324
34.

Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.

Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC.

Rheumatology (Oxford). 2013 May;52(5):832-8. doi: 10.1093/rheumatology/kes270. Epub 2012 Oct 22.

PMID:
23093721
35.

Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.

Gaujoux-Viala C, Paternotte S, Combe B, Dougados M.

Rheumatology (Oxford). 2012 Sep;51(9):1648-54. doi: 10.1093/rheumatology/kes135. Epub 2012 Jun 1.

PMID:
22661552
36.

Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey.

Gaujoux-Viala C, Knevel R, Mandl P, Nagy G, Frank M, Machado P, Hatemi G, Buch MH, Aletaha D, Gossec L; EMEUNET working group.

Ann Rheum Dis. 2012 Aug;71(8):1432-3. doi: 10.1136/annrheumdis-2011-201266. Epub 2012 May 14. No abstract available.

PMID:
22586170
37.

Abatacept therapy and safety management.

Pham T, Bachelez H, Berthelot JM, Blacher J, Claudepierre P, Constantin A, Fautrel B, Gaujoux-Viala C, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Lequerré T, Marolleau JP, Martinez V, Masson C, Mouthon L, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J.

Joint Bone Spine. 2012 Mar;79 Suppl 1:3-84. doi: 10.1016/S1297-319X(12)70011-8.

PMID:
22541956
38.

Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.

Ann Rheum Dis. 2012 Sep;71(9):1478-83. doi: 10.1136/annrheumdis-2011-200891. Epub 2012 Mar 14. Erratum in: Ann Rheum Dis. 2012 Oct;71(10):1756.

PMID:
22419775
39.

Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease.

Gaujoux-Viala C, Giampietro C, Gaujoux T, Ea HK, Prati C, Orcel P, Wendling D, Lioté F.

J Rheumatol. 2012 Feb;39(2):233-9. doi: 10.3899/jrheum.110865. Epub 2011 Dec 15. Review. Erratum in: J Rheumatol. 2012 Apr;39(4):881.

PMID:
22174213
40.

Clinical outcomes in psoriatic arthritis: A systematic literature review.

Palominos PE, Gaujoux-Viala C, Fautrel B, Dougados M, Gossec L.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):397-406. doi: 10.1002/acr.21552. Review.

41.

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.

Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, FitzGerald O, Aletaha D, Balint P, Boumpas D, Braun J, Breedveld FC, Burmester G, Cañete JD, de Wit M, Dagfinrud H, de Vlam K, Dougados M, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger T, Maccarone M, McGonagle D, McHugh N, McInnes IB, Ritchlin C, Sieper J, Tak PP, Valesini G, Vencovsky J, Winthrop KL, Zink A, Emery P; European League Against Rheumatism.

Ann Rheum Dis. 2012 Jan;71(1):4-12. doi: 10.1136/annrheumdis-2011-200350. Epub 2011 Sep 27.

42.

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.

Ash Z, Gaujoux-Viala C, Gossec L, Hensor EM, FitzGerald O, Winthrop K, van der Heijde D, Emery P, Smolen JS, Marzo-Ortega H.

Ann Rheum Dis. 2012 Mar;71(3):319-26. doi: 10.1136/ard.2011.150995. Epub 2011 Jul 28. Review.

PMID:
21803753
43.

On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al.

Landewé R, Gorter S, Gaujoux-Viala C, Gossec L, Smolen JS.

Arthritis Rheum. 2011 Oct;63(10):3182-4; discussion 3184-6. doi: 10.1002/art.30508. No abstract available.

44.

Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.

Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, Maillefert JF.

Joint Bone Spine. 2012 Mar;79(2):149-55. doi: 10.1016/j.jbspin.2011.04.008. Epub 2011 Jun 15. Review.

PMID:
21680221
45.

Langerhans' cell histiocytosis of the liver in adults.

Abdallah M, Généreau T, Donadieu J, Emile JF, Chazouillères O, Gaujoux-Viala C, Cabane J.

Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):475-81. doi: 10.1016/j.clinre.2011.03.012. Epub 2011 May 6.

PMID:
21550330
46.

Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.

J Rheumatol. 2011 Aug;38(8):1576-84. doi: 10.3899/jrheum.101006. Epub 2011 May 1.

PMID:
21532054
47.

Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review.

Mouterde G, Baillet A, Gaujoux-Viala C, Cantagrel A, Wendling D, Le Loët X, Schaeverbeke T.

Joint Bone Spine. 2011 Dec;78(6):587-92. doi: 10.1016/j.jbspin.2011.01.010. Epub 2011 Mar 27. Review.

PMID:
21444233
48.

Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis.

Baillet A, Gaujoux-Viala C, Mouterde G, Pham T, Tebib J, Saraux A, Fautrel B, Cantagrel A, Le Loët X, Gaudin P.

Rheumatology (Oxford). 2011 Jun;50(6):1137-47. doi: 10.1093/rheumatology/keq437. Epub 2011 Jan 28. Review.

PMID:
21278073
49.

Osteomyelitis in adults: an underrecognized clinical entity in immunocompetent hosts. A report of six cases.

Gaujoux-Viala C, Zeller V, Leclerc P, Chicheportiche V, Mamoudy P, Desplaces N, Ziza JM.

Joint Bone Spine. 2011 Jan;78(1):75-9. doi: 10.1016/j.jbspin.2010.03.001. Epub 2010 Aug 25.

PMID:
20800526
50.

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L.

Ann Rheum Dis. 2010 Jun;69(6):1004-9. doi: 10.1136/ard.2009.127225. Epub 2010 May 6. Review.

PMID:
20447954

Supplemental Content

Loading ...
Support Center